Opaleye Management Inc. - XENON PHARMACEUTICALS INC ownership

XENON PHARMACEUTICALS INC's ticker is XENE and the CUSIP is 98420N105. A total of 25 filers reported holding XENON PHARMACEUTICALS INC in Q1 2016. The put-call ratio across all filers is - and the average weighting 0.3%.

Quarter-by-quarter ownership
Opaleye Management Inc. ownership history of XENON PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2018$7,014,000
+387.1%
465,200
+29.2%
1.78%
+149.0%
Q1 2017$1,440,000
-53.8%
360,000
-11.1%
0.72%
-61.0%
Q4 2016$3,119,000
-6.1%
405,000
-1.2%
1.84%
+5.8%
Q3 2016$3,321,000
+37.3%
410,0000.0%1.74%
+7.5%
Q2 2016$2,419,000
-13.5%
410,000
+2.5%
1.62%
-7.3%
Q1 2016$2,796,000
+15.9%
400,000
+33.3%
1.74%
+73.0%
Q4 2015$2,412,000
+93.0%
300,000
+98.3%
1.01%
+63.9%
Q3 2015$1,250,000151,3000.62%
Other shareholders
XENON PHARMACEUTICALS INC shareholders Q1 2016
NameSharesValueWeighting ↓
Ghost Tree Capital, LLC 790,000$12,071,0003.53%
GREAT POINT PARTNERS LLC 700,000$10,696,0002.49%
COMMODORE CAPITAL LP 579,432$8,854,0002.33%
ACUTA CAPITAL PARTNERS, LLC 417,409$6,378,0002.25%
DAFNA Capital Management LLC 406,535$6,212,0001.65%
Tri Locum Partners LP 264,134$4,036,0001.60%
Parkman Healthcare Partners LLC 311,207$4,755,0001.20%
Ghost Tree Capital, LLC 250,000$3,820,0001.12%
Nan Fung Group Holdings Ltd 197,880$3,024,0000.97%
BVF INC/IL 1,571,778$24,017,0000.94%
View complete list of XENON PHARMACEUTICALS INC shareholders